The study by Shirvani et al. analyzed the methylation levels of CpG sites in the VDR primary promoter (800 bp upstream and 200 bp downstream of the ATG start site) in peripheral blood mononuclear cells (PBMCs) from BD patients with respect to CTRs. This evidence concerns the gene VDR and Behcet disease.